BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16236070)

  • 1. The therapeutic dilemma: how to use tadalafil.
    Carosa E; Lombardo F; Martini P; Brandetti F; Jannini EA
    Int J Androl; 2005 Dec; 28 Suppl 2():74-80. PubMed ID: 16236070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tadalafil: new preparation. Slightly more convenient, but poorly assessed in organic disorders.
    Prescrire Int; 2003 Dec; 12(68):213-5. PubMed ID: 14986690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of phosphodiesterase-5 inhibitors by college students.
    Freitas VM; Menezes FG; Antonialli MM; Nascimento JW
    Rev Saude Publica; 2008 Oct; 42(5):965-7. PubMed ID: 18797570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors.
    Dresser MJ; Desai D; Gidwani S; Seftel AD; Modi NB
    Int J Impot Res; 2006; 18(1):104-10. PubMed ID: 16307008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of the application of cialis for erectile dysfunction].
    Koroleva SV; Apolikhin OI; Kovalev VA
    Urologiia; 2003; (6):61-4. PubMed ID: 14708250
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiological aspects of tadalafil safety].
    Talibov OB
    Urologiia; 2009; (3):82, 84-6. PubMed ID: 19670822
    [No Abstract]   [Full Text] [Related]  

  • 9. [The safety of tadalafil in the treatment of erectile dysfunction].
    Wang HY; Huang YF
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):762-4. PubMed ID: 17918720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic dilemma: how to use short-acting PDE5 inhibitor drugs.
    Fabbri A; Aversa A
    Int J Androl; 2005 Dec; 28 Suppl 2():69-73. PubMed ID: 16236069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma.
    Incrocci L; Slagter C; Slob AK; Hop WC
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):439-44. PubMed ID: 16965992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS).
    Martin-Morales A; Haro JM; Beardsworth A; Bertsch J; Kontodimas S;
    Eur Urol; 2007 Feb; 51(2):541-50; discussion 550. PubMed ID: 17084518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New treatment options for erectile dysfunction. Pharmacologic and nonpharmacologic options].
    Sperling H; Lümmen G; Schneider T; Rübben H
    Herz; 2003 Jun; 28(4):314-24. PubMed ID: 12825147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cDNA microarray analysis of differentially expressed genes in penile tissue after treatment with tadalafil.
    Andrade E; Andrade PM; Borra RC; Claro J; Srougi M
    BJU Int; 2008 Feb; 101(4):508-12. PubMed ID: 18005212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tadalafil for erectile dysfunction: excellent safety and tolerance].
    Bai WJ
    Zhonghua Nan Ke Xue; 2009 Jan; 15(1):92-5. PubMed ID: 19288756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tadalafil for erectile dysfunction: efficacy evaluation].
    Wang X
    Zhonghua Nan Ke Xue; 2009 Apr; 15(4):379-83. PubMed ID: 19472916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Carson CC; Lue TF
    BJU Int; 2005 Aug; 96(3):257-80. PubMed ID: 16042713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tadalafil for the treatment of pulmonary arterial hypertension.
    Rosenzweig EB
    Expert Opin Pharmacother; 2010 Jan; 11(1):127-32. PubMed ID: 20001434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Observation of safety and efficacy of tadalafil for men with erectile dysfunction].
    Zhu XW; Li FY; Fang JJ
    Zhonghua Nan Ke Xue; 2006 May; 12(5):421-3, 427. PubMed ID: 16755872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cialis (tadalafil): a new treatment for erectile dysfunction.
    Minhas S; Kalsi JS; Ralph DJ
    Hosp Med; 2003 Oct; 64(10):589-92. PubMed ID: 14584238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.